Acquisition of services to obtain preclinical grade lentiviral vectors in support of the HHS, NIH, national cancer institute (NCI), center for cancer research (CCR), pediatric oncology branch (POB)
Ended Purchase Order Awarded Last action
- Contract number
- 75N91023P00861
- Awardee
-
Vector Biomed Inc. UEI XJUXGT62VKL5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $120,600
Award facts
- Opportunity
-
- Acquisition of Services to Obtain Preclinical Grade Lentiviral Vectors Special Notice · 75N91023Q00157 · Posted Aug 7, 2023
- Contract value 100% obligated
- $120,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gaithersburg, MD 20878, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation of NCI's plasmid shipment, two runs of small-scale lentiviral vector production each resulting in approximately forty (40) milliliters of product, preparation and delivery of vectors and certificates of testing within seven (7) weeks of plasmid receipt. The period of performance is from September 15, 2023 to September 14, 2024. No subcontractors or set aside designations were indicated.
Quick answers
Who was awarded contract 75N91023P00861?
75N91023P00861 was awarded to Vector Biomed Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2023.
How much is contract 75N91023P00861 worth?
The government has obligated $120,600 on 75N91023P00861.
Was contract 75N91023P00861 competed?
The extent of competition for 75N91023P00861 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award